Dr. Jennifer Levy Woelk, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 |
Victoria Anne Clipsham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 |
Dr. Nancy Terrell Maller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 |
Mrs. Kelly Elizabeth Mistry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 434-243-4394 Fax: 434-243-4873 |
Dr. Rebecca Rain Jackson, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1032 Luke St Ste 1, Fort Collins, CO 80524 Phone: 970-568-5810 |
Eduardo Cruz Pareja, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr, Fort Collins, CO 80525 Phone: 970-488-1666 |
Dr. Nathan Michael Smith, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 |
Benjamin R Ruckman, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1640 |
Rebecca Bade, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-484-2846 |
Dr. Nigel James Arruda, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 |
News Archive
Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia.
Despite Brazil's successful prevention campaigns which have contributed to a reduction in risk factors such as smoking, cardiovascular disease (CVD) remains the first cause of death in the country, at 32%. Tobacco consumption and decrease of salt in local diets are some of the risk factors that will be discussed at the 67th Annual Congress of the Brazilian Society of Cardiology which takes place in Recife, Brazil from 14 to 17 September 2012.
› Verified 3 days ago